GLP-1 drugs looked promising for depression. The evidence tells a more complicated story
A systematic review of 43 studies found highly heterogeneous results for GLP-1 receptor agonists across animal models and human research assessing depression-, anxiety-, and stress-related outcomes. No study directly tested…